Skip to main content
Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
883.00
-2.00 (-0.23%)
Apr 24, 2025, 3:30 PM JST

Nxera Pharma Revenue

In the year 2024, Nxera Pharma had annual revenue of 28.84B JPY with 125.87% growth. Nxera Pharma had revenue of 6.85B in the quarter ending December 31, 2024, a decrease of -6.03%.

Revenue
28.84B
Revenue Growth
+125.87%
P/S Ratio
2.75
Revenue / Employee
77.10M
Employees
374
Market Cap
79.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.84B16.07B125.87%
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 20208.84B-884.00M-9.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,170.61B
Takeda Pharmaceutical Company 4,579.02B
Daiichi Sankyo Company 1,795.99B
HOYA Corporation 838.60B
Terumo 1,011.15B
Otsuka Holdings 2,329.86B
Astellas Pharma 1,867.63B
Shionogi & 456.87B
Revenue Rankings

Nxera Pharma News

More News